Signal transduction pathways in acute myetoid leukemia
Promotie: mw. L. Han, 13.15 uur, Academiegebouw, Broerstraat 5, Groningen
Proefschrift: Signal transduction pathways in acute myetoid leukemia
Promotor(s): prof.dr. E. Vellenga
Faculteit: Medische Wetenschappen
Contact: via de persvoorlichters van het UMCG, tel. 050-361 2200, e-mail: voorlichting bvl.umcg.nl
Signal transduction pathways in acute myetoid leukemia
Acute myeloid leukemia (AML) is characterized by the uncontrolled accumulation of abnormal white blood cells in the bone marrow that replace normal blood cells, including red blood cells, platelets and normal white blood cells. The symptoms include fatigue, shortness of breath, bleeding, and high risk of infection. Emerging studies consider that leukemic stem cells (LSCs) initiate and maintain AML, and their quiescent state contributes to resistance of chemotherapy. A number of abnormal signaling pathways have been identified in AML LSCs. A novel inhibitor dasatinib was demonstrated to be a potential inhibitor in a subgroup of AML.
| Last modified: | 13 March 2020 01.16 a.m. |
More news
-
02 July 2025
Relinde Weil reappointed as a member of the Supervisory Board UG
The Minister of Education has reappointed Relinde Weil for a second term as a member of the Supervisory Board of the University of Groningen.
-
-
01 July 2025
Khalaf Alkhalaf elected Alumnus of the Year 2025
Khalaf Alkhalaf has been elected Alumnus of the Year 2025 by the University of Groningen. He has received the award for his commitment to providing good care and guidance to refugees in the Netherlands and the inspiring way in which he shares his...